Cite
HARVARD Citation
Trainer, P. et al. (2018). A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly. European journal of endocrinology. 179 (2), pp. 97-108. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Trainer, P. et al. (2018). A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly. European journal of endocrinology. 179 (2), pp. 97-108. [Online].